Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Thalassemia Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Iron Chelating Drugs
1.2.3 Others
1.3 Market by Application
1.3.1 Global Thalassemia Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Laboratories
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Thalassemia Market Perspective (2018-2033)
2.2 Thalassemia Growth Trends by Region
2.2.1 Global Thalassemia Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Thalassemia Historic Market Size by Region (2018-2023)
2.2.3 Thalassemia Forecasted Market Size by Region (2024-2033)
2.3 Thalassemia Market Dynamics
2.3.1 Thalassemia Industry Trends
2.3.2 Thalassemia Market Drivers
2.3.3 Thalassemia Market Challenges
2.3.4 Thalassemia Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Thalassemia Players by Revenue
3.1.1 Global Top Thalassemia Players by Revenue (2018-2023)
3.1.2 Global Thalassemia Revenue Market Share by Players (2018-2023)
3.2 Global Thalassemia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Thalassemia Revenue
3.4 Global Thalassemia Market Concentration Ratio
3.4.1 Global Thalassemia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Thalassemia Revenue in 2022
3.5 Thalassemia Key Players Head office and Area Served
3.6 Key Players Thalassemia Product Solution and Service
3.7 Date of Enter into Thalassemia Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Thalassemia Breakdown Data by Type
4.1 Global Thalassemia Historic Market Size by Type (2018-2023)
4.2 Global Thalassemia Forecasted Market Size by Type (2024-2033)
5 Thalassemia Breakdown Data by Application
5.1 Global Thalassemia Historic Market Size by Application (2018-2023)
5.2 Global Thalassemia Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Thalassemia Market Size (2018-2033)
6.2 North America Thalassemia Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Thalassemia Market Size by Country (2018-2023)
6.4 North America Thalassemia Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Thalassemia Market Size (2018-2033)
7.2 Europe Thalassemia Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Thalassemia Market Size by Country (2018-2023)
7.4 Europe Thalassemia Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Thalassemia Market Size (2018-2033)
8.2 Asia-Pacific Thalassemia Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Thalassemia Market Size by Region (2018-2023)
8.4 Asia-Pacific Thalassemia Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Thalassemia Market Size (2018-2033)
9.2 Latin America Thalassemia Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Thalassemia Market Size by Country (2018-2023)
9.4 Latin America Thalassemia Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Thalassemia Market Size (2018-2033)
10.2 Middle East & Africa Thalassemia Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Thalassemia Market Size by Country (2018-2023)
10.4 Middle East & Africa Thalassemia Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bluebird bio, Inc.
11.1.1 Bluebird bio, Inc. Company Detail
11.1.2 Bluebird bio, Inc. Business Overview
11.1.3 Bluebird bio, Inc. Thalassemia Introduction
11.1.4 Bluebird bio, Inc. Revenue in Thalassemia Business (2018-2023)
11.1.5 Bluebird bio, Inc. Recent Development
11.2 Acceleron Pharma, Inc.
11.2.1 Acceleron Pharma, Inc. Company Detail
11.2.2 Acceleron Pharma, Inc. Business Overview
11.2.3 Acceleron Pharma, Inc. Thalassemia Introduction
11.2.4 Acceleron Pharma, Inc. Revenue in Thalassemia Business (2018-2023)
11.2.5 Acceleron Pharma, Inc. Recent Development
11.3 Celgene Corporation
11.3.1 Celgene Corporation Company Detail
11.3.2 Celgene Corporation Business Overview
11.3.3 Celgene Corporation Thalassemia Introduction
11.3.4 Celgene Corporation Revenue in Thalassemia Business (2018-2023)
11.3.5 Celgene Corporation Recent Development
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Company Detail
11.4.2 GlaxoSmithKline plc Business Overview
11.4.3 GlaxoSmithKline plc Thalassemia Introduction
11.4.4 GlaxoSmithKline plc Revenue in Thalassemia Business (2018-2023)
11.4.5 GlaxoSmithKline plc Recent Development
11.5 Incyte Corporation
11.5.1 Incyte Corporation Company Detail
11.5.2 Incyte Corporation Business Overview
11.5.3 Incyte Corporation Thalassemia Introduction
11.5.4 Incyte Corporation Revenue in Thalassemia Business (2018-2023)
11.5.5 Incyte Corporation Recent Development
11.6 Gamida Cell
11.6.1 Gamida Cell Company Detail
11.6.2 Gamida Cell Business Overview
11.6.3 Gamida Cell Thalassemia Introduction
11.6.4 Gamida Cell Revenue in Thalassemia Business (2018-2023)
11.6.5 Gamida Cell Recent Development
11.7 Kiadis Pharma
11.7.1 Kiadis Pharma Company Detail
11.7.2 Kiadis Pharma Business Overview
11.7.3 Kiadis Pharma Thalassemia Introduction
11.7.4 Kiadis Pharma Revenue in Thalassemia Business (2018-2023)
11.7.5 Kiadis Pharma Recent Development
11.8 La Jolla Pharmaceutical Company
11.8.1 La Jolla Pharmaceutical Company Company Detail
11.8.2 La Jolla Pharmaceutical Company Business Overview
11.8.3 La Jolla Pharmaceutical Company Thalassemia Introduction
11.8.4 La Jolla Pharmaceutical Company Revenue in Thalassemia Business (2018-2023)
11.8.5 La Jolla Pharmaceutical Company Recent Development
11.9 IONIS Pharmaceuticals
11.9.1 IONIS Pharmaceuticals Company Detail
11.9.2 IONIS Pharmaceuticals Business Overview
11.9.3 IONIS Pharmaceuticals Thalassemia Introduction
11.9.4 IONIS Pharmaceuticals Revenue in Thalassemia Business (2018-2023)
11.9.5 IONIS Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Thalassemia Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Iron Chelating Drugs
Table 3. Key Players of Others
Table 4. Global Thalassemia Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Thalassemia Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Thalassemia Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Thalassemia Market Share by Region (2018-2023)
Table 8. Global Thalassemia Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Thalassemia Market Share by Region (2024-2033)
Table 10. Thalassemia Market Trends
Table 11. Thalassemia Market Drivers
Table 12. Thalassemia Market Challenges
Table 13. Thalassemia Market Restraints
Table 14. Global Thalassemia Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Thalassemia Market Share by Players (2018-2023)
Table 16. Global Top Thalassemia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thalassemia as of 2022)
Table 17. Ranking of Global Top Thalassemia Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Thalassemia Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Thalassemia Product Solution and Service
Table 21. Date of Enter into Thalassemia Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Thalassemia Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Thalassemia Revenue Market Share by Type (2018-2023)
Table 25. Global Thalassemia Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Thalassemia Revenue Market Share by Type (2024-2033)
Table 27. Global Thalassemia Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Thalassemia Revenue Market Share by Application (2018-2023)
Table 29. Global Thalassemia Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Thalassemia Revenue Market Share by Application (2024-2033)
Table 31. North America Thalassemia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Thalassemia Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Thalassemia Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Thalassemia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Thalassemia Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Thalassemia Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Thalassemia Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Thalassemia Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Thalassemia Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Thalassemia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Thalassemia Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Thalassemia Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Thalassemia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Thalassemia Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Thalassemia Market Size by Country (2024-2033) & (US$ Million)
Table 46. Bluebird bio, Inc. Company Detail
Table 47. Bluebird bio, Inc. Business Overview
Table 48. Bluebird bio, Inc. Thalassemia Product
Table 49. Bluebird bio, Inc. Revenue in Thalassemia Business (2018-2023) & (US$ Million)
Table 50. Bluebird bio, Inc. Recent Development
Table 51. Acceleron Pharma, Inc. Company Detail
Table 52. Acceleron Pharma, Inc. Business Overview
Table 53. Acceleron Pharma, Inc. Thalassemia Product
Table 54. Acceleron Pharma, Inc. Revenue in Thalassemia Business (2018-2023) & (US$ Million)
Table 55. Acceleron Pharma, Inc. Recent Development
Table 56. Celgene Corporation Company Detail
Table 57. Celgene Corporation Business Overview
Table 58. Celgene Corporation Thalassemia Product
Table 59. Celgene Corporation Revenue in Thalassemia Business (2018-2023) & (US$ Million)
Table 60. Celgene Corporation Recent Development
Table 61. GlaxoSmithKline plc Company Detail
Table 62. GlaxoSmithKline plc Business Overview
Table 63. GlaxoSmithKline plc Thalassemia Product
Table 64. GlaxoSmithKline plc Revenue in Thalassemia Business (2018-2023) & (US$ Million)
Table 65. GlaxoSmithKline plc Recent Development
Table 66. Incyte Corporation Company Detail
Table 67. Incyte Corporation Business Overview
Table 68. Incyte Corporation Thalassemia Product
Table 69. Incyte Corporation Revenue in Thalassemia Business (2018-2023) & (US$ Million)
Table 70. Incyte Corporation Recent Development
Table 71. Gamida Cell Company Detail
Table 72. Gamida Cell Business Overview
Table 73. Gamida Cell Thalassemia Product
Table 74. Gamida Cell Revenue in Thalassemia Business (2018-2023) & (US$ Million)
Table 75. Gamida Cell Recent Development
Table 76. Kiadis Pharma Company Detail
Table 77. Kiadis Pharma Business Overview
Table 78. Kiadis Pharma Thalassemia Product
Table 79. Kiadis Pharma Revenue in Thalassemia Business (2018-2023) & (US$ Million)
Table 80. Kiadis Pharma Recent Development
Table 81. La Jolla Pharmaceutical Company Company Detail
Table 82. La Jolla Pharmaceutical Company Business Overview
Table 83. La Jolla Pharmaceutical Company Thalassemia Product
Table 84. La Jolla Pharmaceutical Company Revenue in Thalassemia Business (2018-2023) & (US$ Million)
Table 85. La Jolla Pharmaceutical Company Recent Development
Table 86. IONIS Pharmaceuticals Company Detail
Table 87. IONIS Pharmaceuticals Business Overview
Table 88. IONIS Pharmaceuticals Thalassemia Product
Table 89. IONIS Pharmaceuticals Revenue in Thalassemia Business (2018-2023) & (US$ Million)
Table 90. IONIS Pharmaceuticals Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Thalassemia Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Thalassemia Market Share by Type: 2022 VS 2033
Figure 3. Iron Chelating Drugs Features
Figure 4. Others Features
Figure 5. Global Thalassemia Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Thalassemia Market Share by Application: 2022 VS 2033
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Research Institute Case Studies
Figure 10. Laboratories Case Studies
Figure 11. Others Case Studies
Figure 12. Thalassemia Report Years Considered
Figure 13. Global Thalassemia Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Thalassemia Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Thalassemia Market Share by Region: 2022 VS 2033
Figure 16. Global Thalassemia Market Share by Players in 2022
Figure 17. Global Top Thalassemia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thalassemia as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Thalassemia Revenue in 2022
Figure 19. North America Thalassemia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Thalassemia Market Share by Country (2018-2033)
Figure 21. United States Thalassemia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Thalassemia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Thalassemia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Thalassemia Market Share by Country (2018-2033)
Figure 25. Germany Thalassemia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Thalassemia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Thalassemia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Thalassemia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Thalassemia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Thalassemia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Thalassemia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Thalassemia Market Share by Region (2018-2033)
Figure 33. China Thalassemia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Thalassemia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Thalassemia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Thalassemia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Thalassemia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Thalassemia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Thalassemia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Thalassemia Market Share by Country (2018-2033)
Figure 41. Mexico Thalassemia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Thalassemia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Thalassemia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Thalassemia Market Share by Country (2018-2033)
Figure 45. Turkey Thalassemia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Thalassemia Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Bluebird bio, Inc. Revenue Growth Rate in Thalassemia Business (2018-2023)
Figure 48. Acceleron Pharma, Inc. Revenue Growth Rate in Thalassemia Business (2018-2023)
Figure 49. Celgene Corporation Revenue Growth Rate in Thalassemia Business (2018-2023)
Figure 50. GlaxoSmithKline plc Revenue Growth Rate in Thalassemia Business (2018-2023)
Figure 51. Incyte Corporation Revenue Growth Rate in Thalassemia Business (2018-2023)
Figure 52. Gamida Cell Revenue Growth Rate in Thalassemia Business (2018-2023)
Figure 53. Kiadis Pharma Revenue Growth Rate in Thalassemia Business (2018-2023)
Figure 54. La Jolla Pharmaceutical Company Revenue Growth Rate in Thalassemia Business (2018-2023)
Figure 55. IONIS Pharmaceuticals Revenue Growth Rate in Thalassemia Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed